Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarshalls Regulatory News (MSLH)

Share Price Information for Marshalls (MSLH)

Share Price is delayed by 15 minutes
Get Live Data
134.60    3.00 (2.28%)
Bid:
132.10
Ask:
133.10
Spread: 1.00 (0.757%)
Market Cap: £340.39m
MSLH Live PriceLast checked at - London Stock Exchange

Intraday Marshalls Share Chart

Acquisition

12 Dec 2018 07:00

RNS Number : 1815K
Marshalls PLC
12 December 2018
Β 

12 December 2018

LEI: 213800S21IFC367J5V62

Β 

Β 

Β 

Acquisition of Edenhall Holdings Limited

Β 

Β 

Marshalls plc ("Marshalls" or "the Group"), a leading hard landscaping manufacturer, announces today the acquisition of Edenhall Holdings Limited ("Edenhall"), a major UK independent concrete brick manufacturer and a leading supplier of concrete facing bricks, for an initial cash consideration of Β£11.8 million and deferred consideration of up to Β£5.4 million. The acquisition is on a cash free / debt free basis and net debt of Β£5.2Β million has been deducted to derive the initial cash consideration.

Β 

Commenting on the transaction, Martyn Coffey, Chief Executive of Marshalls, said:

Β 

"Marshalls' strategy is to grow both organically and through carefully selected earnings enhancing bolt-on acquisitions with a particular focus on those parts of the market where higher levels of growth are anticipated, including New Build Housing, Road, Rail and Water Management. The acquisition of Edenhall represents a significant step towards achieving further growth in the New Build Housing market. Edenhall is a profitable business with a strong track record of quality, reliability and service, primarily targeting builders' merchants and regional and national housebuilders. The acquisition is in line with our stated strategy of expanding into adjacent building products related to New Build Housing."

Β 

Background

Β 

Marshalls manufactures and distributes hard landscaping products (concrete and natural stone paving), minerals including aggregates, ready mix mortar and street furniture. In the year ended 31 December 2017 the Group reported revenue of Β£430.2 million and profit before tax of Β£52.1 million. It has manufacturing sites in the UK and Belgium, and overseas offices in the US, Dubai and China. It employs around 2,300 people.

Β 

Edenhall was established in 1997 and generated revenue from continuing operations of Β£33.0 million and profit before tax of Β£2.8 million in the financial year ended 31 December 2017. It operates from 10 manufacturing sites across the UK employing around 250 people. It has a head office in Newport in South Wales. Edenhall manufactures and sells a range of solid and perforated concrete bricks, facings and walling products as well as a variety of cast stone products. Edenhall reported gross assets of Β£17.0 million at 31Β December 2017.

Β 

The Transaction

Β 

Under the terms of the acquisition, Marshalls Mono Limited (a wholly owned subsidiary of Marshalls plc) has agreed to acquire 100% of the issued share capital of Edenhall Holdings Limited. The selling shareholders comprise the former directors of Edenhall Holdings Limited. The initial consideration for the shares is Β£11.8 million payable in cash, subject to any adjustment for specified changes in working capital. In addition, deferred consideration is payable up to a maximum of Β£5.4 million and dependent on business performance over a 3 year period. The acquisition will be funded from existing Group facilities, which are being strengthened by an additional Revolving Credit Facility of Β£25 million with RBS. This will support the Group's existing portfolio of committed revolving credit facilities in order to maintain the Group's existing level of facility headroom.

Β 

The acquisition of Edenhall is expected to be earnings enhancing in its first full year after completion and generate returns in excess of the Group's weighted average cost of capital.

Β 

Andrew Cotton, Managing Director of Edenhall Holdings Limited, will remain with the business and will join Marshalls' senior management team.

Β 

Andrew Cotton commented that the joining of two great companies will add real value to our customers and accelerate the growth of Edenhall.

Β 

The information contained within this Announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse Regulation. Upon the publication of this Announcement via a regulatory information service, this inside information is now considered to be in the public domain.

Β 

Conference Call

Β 

There will be a conference call for analysts and investors today at 8.00am with a telephone dial in facility of +44 333 300 0804, access code 926 147 58#. There will also be a playback facility available for analysts and investors who are unable to dial in +44 (0) 333 300 0819, access code 301 273 285#. A Marshalls' Presentation will be available for analysts and investors who are unable to dial in. The presentation can be viewed on Marshalls' website at www.marshalls.co.uk.

Β 

Β 

Β 

Enquiries:

Β 

Martyn Coffey

Chief Executive

Marshalls plc

01422 314777

Jack Clarke

Group Finance Director

Marshalls plc

01422 314777

Charlie Barker

MHP Communications

020 3128 8540

Β 

Β 

Β 

Forward-Looking Statements:

Β 

Any statements in this release, to the extent that they are forward-looking, are subject to risk factors associated with, amongst other things, the economic and business circumstances occurring from time to time in the markets in which Marshalls operates. It is believed that the expectations reflected in these statements are reasonable but they may be affected by a wide range of variables which could cause actual results to differ materially from those currently anticipated. More information about the factors that may affect Marshalls' performance is contained in the Annual Report to shareholders for the year ended 31 December 2017.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
ACQLFFEVFELLLIT
Date   Source Headline
4th Dec 20158:47 amRNSDirector/PDMR Shareholding
4th Nov 20159:38 amRNSDirector/PDMR Shareholding
23rd Oct 20157:00 amRNSAnalyst and Investor Visit
16th Oct 20153:01 pmRNSHolding(s) in Company
12th Oct 201511:51 amRNSHolding(s) in Company
9th Oct 201511:14 amRNSHolding(s) in Company
5th Oct 20154:33 pmRNSDirector/PDMR Shareholding
23rd Sep 20154:10 pmRNSHolding(s) in Company
4th Sep 201511:53 amRNSDirector/PDMR Shareholding
3rd Sep 20154:38 pmRNSDirector/PDMR Shareholding
3rd Sep 201510:10 amRNSHolding(s) in Company
2nd Sep 20151:43 pmRNSHolding(s) in Company
1st Sep 20154:30 pmRNSDirector/PDMR Shareholding
28th Aug 20157:00 amRNSHalf Yearly Report
3rd Aug 20154:15 pmRNSDirector/PDMR Shareholding
6th Jul 20157:00 amRNSTrading Update
3rd Jul 20153:55 pmRNSDirector/PDMR Shareholding
9th Jun 20152:35 pmRNSHolding(s) in Company
3rd Jun 20154:02 pmRNSDirector/PDMR Shareholding
20th May 20153:45 pmRNSAGM Statement
20th May 20157:00 amRNSTrading Update
11th May 20154:09 pmRNSHolding(s) in Company
6th May 20153:57 pmRNSDirector/PDMR Shareholding
9th Apr 20154:17 pmRNSAnnual Financial Report
8th Apr 20153:58 pmRNSHolding(s) in Company
2nd Apr 20155:33 pmRNSDirector/PDMR Shareholding
10th Mar 20154:49 pmRNSDirector/PDMR Shareholding
9th Mar 20153:51 pmRNSDirector Declaration
6th Mar 20157:00 amRNSDirectorate Change
6th Mar 20157:00 amRNSFinal Results
4th Mar 20158:58 amRNSDirector/PDMR Shareholding
4th Feb 20159:13 amRNSDirector/PDMR Shareholding
19th Jan 201510:36 amRNSAppointment of Joint Broker
7th Jan 20157:00 amRNSTrading Update
5th Jan 20154:17 pmRNSDirector/PDMR Shareholding
15th Dec 201411:45 amRNSHolding(s) in Company
3rd Dec 20144:13 pmRNSDirector/PDMR Shareholding
7th Nov 20147:00 amRNSPresentation to Investors and Analysts
5th Nov 20147:00 amRNSInterim Management Statement
4th Nov 201411:06 amRNSDirector/PDMR Shareholding
13th Oct 20145:04 pmRNSHolding(s) in Company
6th Oct 201411:13 amRNSDirector/PDMR Shareholding
2nd Oct 20142:23 pmRNSDirector/PDMR Shareholding
1st Oct 20141:46 pmRNSRetirement of Directors - Remuneration Statement
1st Oct 20141:24 pmRNSDirectorate Change
16th Sep 20143:38 pmRNSHolding(s) in Company
3rd Sep 20144:09 pmRNSDirector/PDMR Shareholding
1st Sep 20142:58 pmRNSHolding(s) in Company
28th Aug 20147:00 amRNSHalf Yearly Report
5th Aug 201410:26 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.